Julian Robertson (Trades, Portfolio) is considered the father of hedge funds. He launched his firm Tiger Management in 1980 with $8 million and turned it into more than $22 billion in the late 1990s.
He manages a portfolio composed of 48 stocks with a total value of $708 million; the following are the largest trades he did during the second quarter.
He increased his stake in JD.com Inc. (JD) by 632.94% with an impact of 13.04% on his portfolio.
The company is an online direct sales company in China. It provides consumers an online retail experience. Through its website www.jd.com and mobile applications, it offers a variety of authentic products.
Net revenues for the second quarter of 2015 had an increase of 61% from the second quarter of 2014. During the last quarter the company launched three new channels on JD Worldwide in Japanese, Australian and U.S., dedicated to offering authentic imported products to customers in China. They join Korean Mall and French Mall, both of which launched in the first quarter of 2015. By the end of the second quarter, it had approximately 76,000 merchants on its online marketplace and a total of 84,322 full-time employees.
The stock is trading with a forward P/E ratio of 42.37 and has been as high as $38 and as low as $21.55 in the past year. It is currently 23.55% below its 52-week high and 34.80% above its 52-week low.
Chase Coleman (Trades, Portfolio) is the main shareholder of the company with 5.13% of outstanding shares, followed by Steve Mandel (Trades, Portfolio) with 3.06% and Julian Robertson (Trades, Portfolio) with 0.23% and Chris Davis (Trades, Portfolio) with 0.11%.
He sold out his stake in Alibaba Group Holding Ltd. (BABA) with an impact of 8.88% on his portfolio.
The company is a holding company and conducts its businesses through its subsidiaries. It is engaged in online and mobile commerce through products, services and technology that enable businesses to operate efficiently and extend their reach to sell to consumers and businesses in the People's Republic of China (the PRC or China) and internationally.
During the second quarter it was focused on building healthy GMV growth, delivering the best consumer experience, and improving the quality and sustainability of merchants. BABA reported a 34% year-over-year increase for GMV and 28% year-over-year increase for revenue.
The stock is trading with a P/E ratio of 23.70 and has been as high as $120.00 and as low as $57.20 in the past year. It is currently 47.16% below its 52-week high and 10.86% above its 52-week low. According to the DCF calculator, the company currently looks overpriced by 60%.
Frank Sands (Trades, Portfolio) is the main shareholder of the company with 0.77% of outstanding shares, followed by Jeremy Grantham (Trades, Portfolio) with 0.54% and PRIMECAP Management (Trades, Portfolio) with 0.29%.
He increased his stake in Netflix Inc. (NFLX) by 524% with an impact of 4.96% on his portfolio.
The company operates as an Internet television network providing TV shows and movies that include original series, documentaries and feature films. It has three segments namely domestic streaming, international streaming and domestic DVD.
During the second quarter iteclipsed 65 million members and EPS increased by 1 cent from the first quarter of year.
The stock is trading with a P/E ratio of 239.00 and has been as high as $129.29 and as low as $45.08 in the past year. It is currently 17.24% below its 52-week high and 137.37% above its 52-week low. According to the DCF calculator, the company currently looks overpriced by 905%.
Chase Coleman (Trades, Portfolio) holds the largest stake of outstanding shares of the company, 4.24%, the second one is Steven Cohen (Trades, Portfolio) with 0.19% followed by Julian Robertson with 0.11%.
He bought 861,000 shares of DeVry Education Group Inc. (DV) with an impact of 3.64% on his portfolio.
The company offers programs in business, healthcare, accounting, finance, law and technology. It serves students in postsecondary education. Its segments are Medical and Healthcare, International and Professional Education and Business, Technology and Management.
DeVry reported the last quarter with a decrease of 1.3% for revenue and $6 million decrease for the net income. Also diluted earnings per share was 9 cents less compared to the same quarter of a year before.
The stock is trading with a P/E ratio of 12.50 and has been as high as $49.61 and as low as $24 in the past year. It is currently 45.52% below its 52-week high and 12.63% above its 52-week low. According to the DCF calculator, the company currently looks undervalued by 52%.
The main shareholder of the company is Charles de Vaulx (Trades, Portfolio) with 11.97% of outstanding shares, followed by the hedge fund First Pacific Advisors (Trades, Portfolio) with 3.99% and FPA Capital Fund (Trades, Portfolio) with 1.97%
He bought 244,000 shares in Macquarie Infrastructure Corp. (MIC) with an impact of 2.85% on his portfolio.
The company owns, operates and invests in a diversified group of infrastructure businesses that provide basic services to businesses and individuals in the U.S.
Macquarie reported the second quarter with an increase of 16.8% for quarterly cash dividend, over second quarter in a year before. The company is confident in delivering year on year growth in dividend of 14% in each of 2015 and 2016.
The stock is trading with a P/E ratio of 6.20 and has been as high as $87.88 and as low as $62.58 in the past year. It is currently 14.95% below its 52-week high and 19.43% above its 52-week low. According to the DCF calculator, the company currently looks undervalued by 98%.
Mario Gabelli (Trades, Portfolio) is the main shareholder of the company with 0.54% of outstanding shares. After this buy Julian Robertson (Trades, Portfolio) jumped on second position with his stake of 0.31% overcoming Jim Simons (Trades, Portfolio) on third position with 0.26% of outstanding shares of the company.
He sold out shares of Alnylam Pharmaceuticals Inc. (ALNY) with an impact of 2.83% on his portfolio.
It is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi; during the last quarter the company received Orphan Drug Designation (ODD) from the United States Food and Drug Administration (FDA) for revusiran. ALNY had $1.4 billion in cash as of the end of the second quarter of 2015 and will continues to maintain a very strong balance sheet.
The stock is trading with a forward P/E ratio of 23.64 and has been as high as $140 and as low as $72.80 in the past year. It is currently 40.53% below its 52-week high and 14.37% above its 52-week low.
Vanguard Health Care Fund (Trades, Portfolio) holds the largest stake of outstanding shares of the company with 7.2 % that is 1.47% of its total assets, followed by John Griffin (Trades, Portfolio) with 1.27% that is 1.45% of total assets he manages.
Also check out:
